Prostate Cancer Prostatic Dis
January 2024
Background: Refinement of the risk classification for localized prostate cancer is warranted to aid in clinical decision making. A systematic analysis was undertaken to evaluate the prognostic ability of three genomic classifiers, Decipher, GPS, and Prolaris, for biochemical recurrence, development of metastases and prostate cancer-specific mortality in patients with localized prostate cancer.
Methods: Data sources: MEDLINE, Embase, and Web of Science were queried for reports published from January 2010 to April 2022.